performed whole exome and RNA sequencing analyses for purified CD138+ cells from paired MM patients before and after therapy with different anti-myeloma drugs to compare genomic and transcriptomic changes as well as clonal evolution under treatment pressure. This evidence concerns the gene SDC1 and plasma cell myeloma.